Group One Trading’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$465K Sell
19,900
-30,200
-60% -$656K ﹤0.01% 3418
2025
Q4
$1.05M Sell
50,100
-92,400
-65% -$1.61M ﹤0.01% 2834
2025
Q3
$2.19M Sell
142,500
-13,000
-8% -$170K ﹤0.01% 2222
2025
Q2
$1.46M Buy
155,500
+106,800
+219% +$1.18M ﹤0.01% 2423
2025
Q1
$598K Buy
48,700
+8,000
+20% +$113K ﹤0.01% 2904
2024
Q4
$538K Buy
40,700
+23,600
+138% +$404K ﹤0.01% 3106
2024
Q3
$329K Buy
17,100
+15,500
+969% +$320K ﹤0.01% 3178
2024
Q2
$32.8K Sell
1,600
-5,800
-78% -$121K ﹤0.01% 4846
2024
Q1
$176K Sell
7,400
-18,000
-71% -$401K ﹤0.01% 3673
2023
Q4
$549K Sell
25,400
-55,200
-68% -$849K ﹤0.01% 2995
2023
Q3
$1.17M Buy
80,600
+80,100
+16,020% +$1.52M ﹤0.01% 2104
2023
Q2
$10.5K Buy
+500
New +$10.4K ﹤0.01% 6370
2022
Q4
Sell
-100
Closed -$2K 8029
2022
Q3
$2K Hold
100
﹤0.01% 7204
2022
Q2
$2K Hold
100
﹤0.01% 7443
2022
Q1
$2K Sell
100
-1,300
-93% -$21.9K ﹤0.01% 7750
2021
Q4
$31K Sell
1,400
-5,100
-78% -$94.2K ﹤0.01% 6709
2021
Q3
$124K Buy
6,500
+5,300
+442% +$88.3K ﹤0.01% 5694
2021
Q2
$21K Buy
1,200
+800
+200% +$14.7K ﹤0.01% 7162
2021
Q1
$9K Hold
400
﹤0.01% 7092
2020
Q4
$9K Sell
400
-4,700
-92% -$97.5K ﹤0.01% 5836
2020
Q3
$75K Sell
5,100
-22,500
-82% -$343K ﹤0.01% 4387
2020
Q2
$409K Sell
27,600
-17,200
-38% -$262K ﹤0.01% 2801
2020
Q1
$491K Buy
44,800
+39,400
+730% +$370K ﹤0.01% 2062
2019
Q4
$47K Hold
5,400
﹤0.01% 4034
2019
Q3
$40K Buy
5,400
+5,000
+1,250% +$45.5K ﹤0.01% 4078
2019
Q2
$4K Hold
400
﹤0.01% 4650
2019
Q1
$2K Buy
400
+100
+33% +$570 ﹤0.01% 4601
2018
Q4
$1K Sell
300
-28,300
-99% -$155K ﹤0.01% 4747
2018
Q3
$231K Buy
28,600
+28,500
+28,500% +$203K ﹤0.01% 2915
2018
Q2
$1K Sell
100
-22,600
-100% -$222K ﹤0.01% 5000
2018
Q1
$323K Buy
+22,700
New +$241K ﹤0.01% 2387

Other funds holding SNDX